Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Prospective Double-blind Study for the Use of Aspirin During Transurethral Surgery of the Bladder or the Prostate

This study has been withdrawn prior to enrollment.
(difficult enrollment, focus of study no longer of interest)
Sponsor:
Information provided by (Responsible Party):
University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier:
NCT00861367
First received: March 12, 2009
Last updated: November 17, 2016
Last verified: November 2016

March 12, 2009
November 17, 2016
September 2008
January 2009   (final data collection date for primary outcome measure)
Blood loss [ Time Frame: intraoperative, 6 hours post op, 3 days postop ] [ Designated as safety issue: Yes ]
Same as current
Complete list of historical versions of study NCT00861367 on ClinicalTrials.gov Archive Site
Reoperation rates [ Time Frame: during hospitalization ] [ Designated as safety issue: Yes ]
Same as current
Not Provided
Not Provided
 
Prospective Double-blind Study for the Use of Aspirin During Transurethral Surgery of the Bladder or the Prostate
Prospektive Doppel-Blind-randomisierte Studie Zur Verwendung Von Aspirin Bei Transurethralen Operationen
Aspirin is very common in older patients. Therefore many of the investigators patients have aspirin. The aim of the study is to proof that Transurethral Surgery of the bladder or the prostate can be performed with aspirin.
Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Caregiver, Investigator)
Primary Purpose: Prevention
  • Blood Loss, Surgical
  • Intraoperative Complications
  • Re-operation Rates in Patients With Aspirin Treatment
Drug: transurethral surgery with or without aspirin
aspirin 100mg once a day, transurethral surgery with or without aspirin
Other Name: Asprin cardio 100mg
  • Active Comparator: 1
    aspirin 100mg
    Intervention: Drug: transurethral surgery with or without aspirin
  • Placebo Comparator: 2
    empty capsule
    Intervention: Drug: transurethral surgery with or without aspirin
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Withdrawn
0
January 2009
January 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Transurethral surgery of the bladder or prostate, informed consent, age over 18

Exclusion Criteria:

  • Oral anticoagulation,
Both
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Switzerland
 
NCT00861367
05/08
No
Not Provided
Not Provided
University Hospital, Basel, Switzerland
University Hospital, Basel, Switzerland
Not Provided
Study Chair: Thomas C Gasser, Prof Department of Urology, Liestal
University Hospital, Basel, Switzerland
November 2016

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP